Document Detail


Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo.
MedLine Citation:
PMID:  18996224     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Propofol, a rapidly acting, short duration, intravenous hypnotic anesthetic induction agent, is often used in clinical situations where myocardial ischemia/ reperfusion (I/R) injury is a threat. The aim of the present study was to evaluate the protective effect of propofol on myocardial I/R injury in rat due to apoptosis. Myocardial I/R injury were induced by occluding the left anterior descending (LAD) coronary artery for 25 min followed by either 2 h or 6 h reperfusion. Apoptosis was evaluated by Western blot analysis (Bcl-2, Bax expression), DNA strand breaks, TUNEL analysis and measuring myocardial caspase-3 activity. Propofol significantly reduced infarct size and improved I/R-induced myocardial contractile dysfunction by improving left ventricular diastolic pressure and positive and negative maximal values of the first derivative (+dp/dt) of left ventricular pressure. Propofol increased Bcl-2/Bax expression ratio and decreased caspase-3 activity in I/R rat hearts, which resulted in reduction of myocardial apoptosis as evidenced by TUNEL analysis and DNA laddering experiments. In an in vitro study, propofol increased H9c2 cell viability against oxidative stress induced by glucose oxidase (GOX) in a dose-dependent manner. These data suggest propofol limits I/R injury with an associated reduction in apoptotic cell death in vivo.
Authors:
Yong Chun Jin; Wooyeol Kim; Yu Mi Ha; Il Woo Shin; Ju Tae Sohn; Hye Jung Kim; Han Geuk Seo; Jea Heun Lee; Ki Churl Chang
Related Documents :
6742324 - Blunt cardiac trauma.
8461514 - Myocardial stunning and preconditioning: age, species, and model related differences: r...
15280094 - Lymphatic diversion prevents myocardial edema following mesenteric ischemia/reperfusion.
1810434 - Cardioprotective effects of sodium gamma-hydroxybutyrate (ghb) on brain induced myocard...
477344 - Recovery from alexia without agraphia: report of an autopsy.
7994824 - Radiofrequency ablation of atrial flutter. efficacy of an anatomically guided approach.
Publication Detail:
Type:  Journal Article     Date:  2008-10-28
Journal Detail:
Title:  Vascular pharmacology     Volume:  50     ISSN:  1537-1891     ISO Abbreviation:  Vascul. Pharmacol.     Publication Date:    2009 Jan-Feb
Date Detail:
Created Date:  2008-12-16     Completed Date:  2009-04-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130615     Medline TA:  Vascul Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  71-7     Citation Subset:  IM    
Affiliation:
Department of Pharmacology School of Medicine and Institute of Health Sciences, Gyeongsang National University, Jinju, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthetics, Intravenous / pharmacology
Animals
Apoptosis / drug effects*
Caspase 3 / analysis
Hypnotics and Sedatives / pharmacology
In Situ Nick-End Labeling
Male
Myocardial Contraction / drug effects
Myocardial Reperfusion Injury / drug therapy*,  pathology,  physiopathology
Myocytes, Cardiac / drug effects,  metabolism,  pathology
Propofol / pharmacology*
Rats
Rats, Sprague-Dawley
bcl-2-Associated X Protein / metabolism
Chemical
Reg. No./Substance:
0/Anesthetics, Intravenous; 0/Hypnotics and Sedatives; 0/bcl-2-Associated X Protein; 2078-54-8/Propofol; EC 3.4.22.-/Caspase 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of polar membrane lipids of the extremely halophilic bacterium Salinibacter ruber a...
Next Document:  Effects of testosterone therapy on muscle performance and physical function in older men with mobili...